SEC Form 4 · accession 0000884731-16-000043
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Haluska
Officer — SVP, Clinical R&D, CMO
Period of report
Apr 29, 2016
Accepted (ET)
May 2, 2016 · 5:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 29, 2016 | M | 17,334 | $0.00 | A | 164,345 | D | |
| Common StockF2 | Apr 29, 2016 | F | 5,634 | $7.18 | D | 158,711 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F4 | $0.00 | Apr 29, 2016 | M | 17,334 | D | — | — | Common Stock | 17,334 | 0 | D |
Explanation of responses
- F1shares were acquired upon the vesting of an RSU granted April 29, 2015
- F2Represents shares withheld to satisfy withholding tax requirements
- F3Restricted stock units vest as to 33-1/3% of the award on each of April 29, 2016, April 29, 2017 and April 29, 2018.
- F4N/A